Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
|Articles|July 3, 2008
Message to new APhA leader: This is what we want you to do
As John Gans steps down from his role with the American Pharmacists Association, all eyes are on successor's role.
Advertisement
With John Gans stepping down from the helm of the American Pharmacists Association, what would pharmacists like his successor to do? That was Drug Topics'
- fight for better working conditions for pharmacists (20%),
- unify the profession (19%),
- secure pharmacists' place as an integral part of the healthcare team (15%),
- help obtain adequate reimbursement for pharmacy (15%),
- and inspire pharmacists to expand from dispensing to medication therapy management (10%). The poll drew a total of 171 responses.
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Related to this article
The update adds efficacy and safety data on adults newly diagnosed with pulmonary arterial hypertension.
Mark Garofoli, PharmD, BCGP, CPE, CTTS, explains how to guide patients past crowded combination products, uncertain decongestants, and hidden risks in OTC aisles.
Chad Worz, PharmD, BCGP, FASCP, explains why the Main Street Pharmacy Access Act's reimbursement provisions are key to unlocking pharmacy's clinical future.
Cohort studies found no clear cardiovascular benefit from PPV23 vaccination, leaving its role in cardiovascular prevention unresolved.
A high-dose flu vaccine lowered flu- and pneumonia-related hospital stays in patients with chronic lung disease, reinforcing flu and pneumococcal vaccinations.
In a review of records assessing patients with type 2 diabetes, researchers provide a comprehensive detail of strategies leading to diabetes remission though gaps persist.
A guide built from conversations with pharmacists on social media and independent pharmacy owners.
Advertisement
Advertisement
Trending on Drug Topics
1
GLP-1 Therapy Must Prioritize Metabolic Quality Over Weight Loss
2
COVID-19 Vaccine Hesitancy in 2026: How Attitudes Have Shifted
3
FDA Approves Update for Winrevair Based on Phase 3 HYPERION Trial Data
4
PPV23 Vaccination Found to Not Reduce Cardiovascular Risk
5